Factor Xa Inhibitors in CAD/PAD: Where Are We Today?
Drs Eikelboom, Weitz, and Bode provide the latest information on the use of dual pathway inhibition to effectively treat patients with CAD and PAD.
Earn Credit / Learning Objectives & Disclosures
---
Full URLs:
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/929254?src=mkm_podcast_addon_929254
Create your
podcast in
minutes
It is Free